Sisram Medical Ltd
SRAMF
$0.5512
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -3.88% | -3.88% | -1.68% | -1.68% | 4.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.88% | -3.88% | -1.68% | -1.68% | 4.28% |
| Cost of Revenue | -6.03% | -6.03% | -4.38% | -4.38% | -5.07% |
| Gross Profit | -2.50% | -2.50% | 0.01% | 0.01% | 11.32% |
| SG&A Expenses | 0.00% | 0.00% | 7.64% | 7.64% | 26.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 74.04% | 74.04% | 148.53% | 148.53% | -24.85% |
| Total Operating Expenses | -1.99% | -1.99% | 2.37% | 2.37% | 7.87% |
| Operating Income | -22.80% | -22.80% | -30.81% | -30.81% | -21.81% |
| Income Before Tax | 8.66% | 8.66% | -28.98% | -28.98% | -22.54% |
| Income Tax Expenses | -1.27% | -1.27% | -21.96% | -21.96% | 41.19% |
| Earnings from Continuing Operations | 10.27% | 10.27% | -29.71% | -29.71% | -27.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 8.25% | 8.25% | -2,039.66% | -2,039.66% | -37,775.00% |
| Net Income | 12.49% | 12.49% | -42.05% | -42.05% | -35.55% |
| EBIT | -22.80% | -22.80% | -30.81% | -30.81% | -21.81% |
| EBITDA | -16.73% | -16.73% | -19.31% | -19.31% | -13.57% |
| EPS Basic | 11.85% | 11.85% | -42.08% | -42.08% | -35.71% |
| Normalized Basic EPS | -18.28% | -18.28% | -47.14% | -47.14% | -34.51% |
| EPS Diluted | 11.85% | 11.85% | -41.79% | -42.08% | -35.71% |
| Normalized Diluted EPS | -18.28% | -18.28% | -46.76% | -46.76% | -34.51% |
| Average Basic Shares Outstanding | 0.20% | 0.20% | 0.22% | 0.22% | 0.23% |
| Average Diluted Shares Outstanding | 0.18% | 0.18% | -0.18% | -0.18% | 0.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.20% | -0.20% | -- | -- | 0.75% |